Chief Financial Officer · IRADIMED CORP (IRMD)

John Glenn

FY2025 is the first fiscal year CompBrief holds for John Glenn as a named executive officer of IRADIMED; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2025

$609,994

Compensation figures as of the proxy filed April 30, 2026 (DEF 14A).

John Glenn compensation by year

IRADIMED Summary Compensation Table · the one fiscal year held
In US dollars, as IRADIMED reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2025
Salary$378,933
Bonus$0
Stock awards$0
Option awards$0
Non-equity incentive$200,000
Pension and deferred compensation$0
All other$31,061
Total$609,994

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: IRADIMED CORP DEF 14A filed April 30, 2026, accession 0001628280-26-028903, and prior-year filings. Open the filing on EDGAR.

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
PSU14,360$1,396,941—
PSU10,872$1,057,628—
RSU7,180$698,470—
RSU5,796$563,835—
RSU3,624$352,543—

Per the Outstanding Equity Awards at Fiscal Year-End table in IRADIMED CORP's FY2025 proxy; value at the fiscal year-end close, as the company printed it.

IRADIMED’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Roger SusiPresident and Chief Executive Officer$780,598
John Glenn · this pageChief Financial Officer$609,994
Jeffrey ChiprinChief Commercial Officer$529,360

The full IRADIMED compensation record

free company brief

This page is one person within IRADIMED's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order IRADIMED's full Executive Compensation Report with peer benchmarking.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are IRADIMED's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Velarion Pro: every company page, peer tools and exports, one seat

One email to you when Pro opens, and nothing else. Privacy